Full Title
Efficacy of Molecularly Driven, Time-limited Treatment with Ropeg-interferon in Newly Diagnosed Patients with JAK2-mutant Polycythemia Vera - a Multicenter, Single-arm, Phase II StudyPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Raajit Rampal’s office at 646-608-3746.
Protocol
26-202
Phase
Phase II (phase 2)
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07886801
ClinicalTrials.gov